Treatment of Human Hepatocellular Carcinoma by the Oncolytic Herpes Simplex Virus G47delta

Cancer Cell International - United Kingdom
doi 10.1186/s12935-014-0083-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Anti-Tumor Effect of Oncolytic Herpes Simplex Virus G47delta on Human Nasopharyngeal Carcinoma

Chinese Journal of Cancer
2011English

Construction of an Oncolytic Herpes Simplex Virus That Precisely Targets Hepatocellular Carcinoma Cells

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

Treatment of Breast Cancer Stem Cells With Oncolytic Herpes Simplex Virus

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2012English

Treatment of Implantable NF2 Schwannoma Tumor Models With Oncolytic Herpes Simplex Virus G47Δ

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2007English

Oncolytic Herpes Simplex Virus ICP47 Deletion Reverses Tumor Immune Evasion

Yangtze Medicine
2018English

A Potent Oncolytic Herpes Simplex Virus for the Therapy of Advanced Prostate Cancer

2004English

A Fusogenic Oncolytic Herpes Simplex Virus for Therapy of Advanced Ovarian Cancer

2005English

Effect of Γ34.5 Deletions on Oncolytic Herpes Simplex Virus Activity in Brain Tumors

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2012English

Combination Effect of Oncolytic Adenovirus Therapy and Herpes Simplex Virus Thymidine Kinase/Ganciclovir in Hepatic Carcinoma Animal Models

Acta Pharmacologica Sinica
MedicinePharmacology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy